ClinicalTrials.gov
ClinicalTrials.gov Menu

Pediatric Multicenter Study of REPEL-CV

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00116233
Recruitment Status : Unknown
Verified June 2005 by SyntheMed.
Recruitment status was:  Recruiting
First Posted : June 28, 2005
Last Update Posted : June 28, 2005
Sponsor:
Information provided by:
SyntheMed

Brief Summary:
This trial will study REPEL-CV for reducing post operative adhesions following cardiovascular (cv) surgery.

Condition or disease Intervention/treatment Phase
Adhesions Device: REPEL-CV Phase 2

Detailed Description:
- Efficacy at second sternotomy

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Peds. Multicenter Study

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Adhesions





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 1 Year   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Stage sternotomies

Exclusion Criteria:

  • Delayed closure beyond 5 days

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00116233


Contacts
Contact: Eli Pines, Ph.D. 212-460-9488

Locations
United States, New Jersey
SyntheMed Recruiting
Little Silver, New Jersey, United States, 07739
Contact: Eli Pines, Ph.D.    212-460-9488      
Sponsors and Collaborators
SyntheMed
Investigators
Study Director: Eli Pines SyntheMed

ClinicalTrials.gov Identifier: NCT00116233     History of Changes
Other Study ID Numbers: LMS0104RCV
First Posted: June 28, 2005    Key Record Dates
Last Update Posted: June 28, 2005
Last Verified: June 2005

Keywords provided by SyntheMed:
post operative adhesions

Additional relevant MeSH terms:
Tissue Adhesions
Cicatrix
Fibrosis
Pathologic Processes